Insmed
INSM
$25.59
Share price
3.52%
Change (1 day)
26.87%
Change (1 year)
Categories
P/S ratio for Insmed (INSM)
P/S ratio as of May 2024 (TTM): 12.5
According to Insmed's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 12.4555. At the end of 2023 the company had a P/S ratio of 14.5.
P/S ratio history for Insmed from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 14.5 | 31.67% |
| 2022 | 11.0 | -35.52% |
| 2021 | 17.1 | -17.05% |
| 2020 | 20.6 | 31.43% |
| 2019 | 15.7 | -84.78% |
| 2018 | 103 | |
| 2017 | N/A | |
| 2016 | N/A | |
| 2015 | N/A | |
| 2014 | N/A | -100% |
| 2013 | 57.9 | |
| 2012 | N/A | -100% |
| 2011 | 17.1 | 20.19% |
| 2010 | 14.3 | 47.61% |
| 2009 | 9.67 | 101.06% |
| 2008 | 4.81 | -64.28% |
| 2007 | 13.5 | -85.03% |
| 2006 | 89.9 | -91.02% |
| 2005 | > 1000 | 38.83% |
| 2004 | 721 | -5.21% |
| 2003 | 760 | 9874.26% |
| 2002 | 7.62 | -98.21% |
| 2001 | 425 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 4.01 | -67.81% | 🇨🇭 Switzerland |
 Gilead Sciences GILD | 3.01 | -75.81% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | 10.5 | -15.45% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | 9.95 | -20.12% | 🇺🇸 USA |
 Aerie Pharmaceuticals AERI | 3.52 | -71.72% | 🇺🇸 USA |
 Array Technologies ARRY | 1.20 | -90.37% | 🇺🇸 USA |